These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24044572)

  • 1. Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.
    Várady G; Cserepes J; Németh A; Szabó E; Sarkadi B
    Biomark Med; 2013 Oct; 7(5):803-19. PubMed ID: 24044572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine.
    Blokzijl A; Friedman M; Pontén F; Landegren U
    J Intern Med; 2010 Sep; 268(3):232-45. PubMed ID: 20695973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.
    Shukla HD; Vaitiekunas P; Cotter RJ
    Proteomics; 2012 Oct; 12(19-20):3085-104. PubMed ID: 22890602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane proteomics: the development of diagnostics based on protein shedding.
    Lai ZW; Steer DL; Smith AI
    Curr Opin Mol Ther; 2009 Dec; 11(6):623-31. PubMed ID: 20072939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein microarrays and personalized medicine].
    Yu X; Schneiderhan-Marra N; Joos TO
    Ann Biol Clin (Paris); 2011; 69(1):17-29. PubMed ID: 21463992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface biomarkers of embryonic stem cells.
    Nagano K; Yoshida Y; Isobe T
    Proteomics; 2008 Oct; 8(19):4025-35. PubMed ID: 18763704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational implications of inflammatory biomarkers and cytokine networks in psychoneuroimmunology.
    Yan Q
    Methods Mol Biol; 2012; 934():105-20. PubMed ID: 22933143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for multiple sclerosis.
    Villoslada P
    Drug News Perspect; 2010 Nov; 23(9):585-95. PubMed ID: 21152453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic profiling joins personalized cancer medicine.
    Heyn H; Méndez-González J; Esteller M
    Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Nana-Sinkam SP; Fabbri M; Croce CM
    Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of novel biomarkers for Personalized medication for atopic dermatitis].
    Ohta S; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Masuoka M; Izuhara K
    Rinsho Byori; 2013 Mar; 61(3):247-55. PubMed ID: 23785795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized network-based treatments in oncology.
    Robin X; Creixell P; Radetskaya O; Santini CC; Longden J; Linding R
    Clin Pharmacol Ther; 2013 Dec; 94(6):646-50. PubMed ID: 23995267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays.
    Lohmann S; Herold A; Bergauer T; Belousov A; Betzl G; Demario M; Dietrich M; Luistro L; Poignée-Heger M; Schostack K; Simcox M; Walch H; Yin X; Zhong H; Weisser M
    Methods; 2013 Jan; 59(1):10-9. PubMed ID: 22796720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NanoMonitor: a miniature electronic biosensor for glycan biomarker detection.
    Nagaraj VJ; Aithal S; Eaton S; Bothara M; Wiktor P; Prasad S
    Nanomedicine (Lond); 2010 Apr; 5(3):369-78. PubMed ID: 20394531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
    Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane proteomics for leukemia classification and drug target identification.
    Kohnke PL; Mulligan SP; Christopherson RI
    Curr Opin Mol Ther; 2009 Dec; 11(6):603-10. PubMed ID: 20072937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microspot immunoassay-based analysis of plasma protein profiles for biomarker discovery strategies.
    Sonntag J; Mannsperger H; Jöcker A; Korf U
    Methods Mol Biol; 2011; 785():237-45. PubMed ID: 21901604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.